Compare

Compare stocks side by side

Pick up to 3 companies to see where each one is stronger or weaker.

AXRXANIP

Amexdrug Corporation

AXRX · $0.00

69Good

ANI Pharmaceuticals, Inc.

ANIP · $72.61

76Strong

Area by area

Overall Quant Score

How does it look overall? (out of 100)

AXRX

69/100

ANIP

76/100

Quality

Is it a profitable, well-run business?

AXRX

0.3/10

ANIP

4.9/10

Growth

Is the company growing?

AXRX

3.4/10

ANIP

9.5/10

Valuation

Is the price reasonable? (higher = cheaper)

AXRX

10.0/10

ANIP

9.9/10

Risk

How risky are the shares? (higher = lower risk)

AXRX

8.5/10

ANIP

8.1/10

Momentum

Is the share price trending up?

AXRX

7.9/10

ANIP

6.0/10

Financial strength

Is the balance sheet healthy?

AXRX

6.4/10

ANIP

6.0/10

The balanced view

Model-generated

Amexdrug Corporation

This company scores above average, with a reasonable valuation and a relatively low-risk profile, although its profitability is thin.

Leads on: valuation, risk, momentum, financial strength

Best feature: reasonable valuation (P/E (TTM): 0.5x)

Watch out: profitability is thin (Return on equity (TTM): 2.5%)

ANI Pharmaceuticals, Inc.

This company scores well across most areas, with a reasonable valuation and solid growth.

Leads on: quality, growth

Best feature: reasonable valuation (PEG: 0.01)

Watch out: weakest area: business quality (Return on invested capital (TTM): 9.3%)

Different strengths suit different goals — a higher score in one area doesn’t make a stock the better choice for everyone.